Cargando…

The paramount importance of serological surveys of SARS-CoV-2 infection and immunity

Detalles Bibliográficos
Autor principal:	Goudsmit, Jaap
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173354/ https://www.ncbi.nlm.nih.gov/pubmed/32318914 http://dx.doi.org/10.1007/s10654-020-00635-2

Ejemplares similares

Masks and thermometers: Paramount measures to stop the rapid spread of SARS-CoV-2 in the United States
por: Wu, Erxi, et al.
Publicado: (2020)

On the importance of population-based serological surveys of SARS-CoV-2 without overlooking their inherent uncertainties
por: Kritsotakis, Evangelos I.
Publicado: (2020)

Evaluation of High-Throughput Serological Tests for SARS-CoV-2
por: Loeffelholz, Michael J.
Publicado: (2020)

Renaming the SARS‐CoV‐2 Omicron sublineages as SARS‐CoV‐3 is contrary to nomenclature standards based on evolutionary and serological evidence
por: Qi, Zhongtian, et al.
Publicado: (2022)

Evaluation of vaccine effectiveness against SARS‐CoV‐2 variants by serological epitope profiling
por: Li, Cheng, et al.
Publicado: (2023)

Covid‐19 will not “magically disappear”: Why access to widespread testing is paramount
por: George, Paul E., et al.
Publicado: (2020)

Immunodominant epitopes based serological assay for detecting SARS-CoV-2 exposure: Promises and challenges
por: Quadeer, Ahmed Abdul
Publicado: (2020)

Acute exercise and immune response in previously SARS CoV-2 infection
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

The Paramount story /
por: Eames, John Douglas

A serological survey of SARS-CoV-2 in cat in Wuhan
por: Zhang, Qiang, et al.
Publicado: (2020)

Serological survey of SARS-CoV-2 in companion animals in China
por: Wang, Aiping, et al.
Publicado: (2022)

Implementing digital passports for SARS-CoV-2 immunization in Canada
por: Wilson, Kumanan, et al.
Publicado: (2021)

A framework for monitoring population immunity to SARS-CoV-2
por: Lopman, Benjamin A., et al.
Publicado: (2021)

Pay attention to SARS‐CoV‐2 infection in children
por: Xie, Zhengde
Publicado: (2020)

Abrupt decreases in infectivity of SARS-CoV-2 in aerosols
por: Löndahl, Jakob, et al.
Publicado: (2022)

ALDO-DHF & Paramount
por: ElGuindy, Ahmed M
Publicado: (2013)

Tracking SARS-CoV-2 infection in India with serology
por: John, Jacob, et al.
Publicado: (2021)

A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection
por: Casanova, Jean-Laurent, et al.
Publicado: (2020)

Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy
por: Ikizler, T. Alp, et al.
Publicado: (2021)

His Majesty the Pig: His Paramount Importance in the Great War
Publicado: (1918)

SARS-CoV-2 vaccination for immune-comprised patients: More is required
por: Li, Hui, et al.
Publicado: (2021)

The complexities of SARS-CoV-2 serology
por: Houlihan, Catherine F, et al.
Publicado: (2020)

Acute kidney injury in SARS-CoV-2 infected patients
por: Fanelli, Vito, et al.
Publicado: (2020)

Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing
por: Muthumani, Kar, et al.
Publicado: (2021)

microRNA Heterogeneity, Innate-Immune Defense and the Efficacy of SARS-CoV-2 Infection—A Commentary
por: Lukiw, Walter J.
Publicado: (2021)

Zoonotic origins of human coronavirus 2019 (HCoV-19 / SARS-CoV-2): why is this work important?
por: Wong, Gary, et al.
Publicado: (2020)

Consulting the Oracle of SARS-CoV-2 Infection
por: Lemieux, Jacob E, et al.
Publicado: (2021)

Pathogenicity of SARS‐CoV‐2 Omicron
por: Chu, Hin, et al.
Publicado: (2022)

Antigenic imprinting in SARS‐CoV‐2
por: Reincke, S. Momsen, et al.
Publicado: (2022)

SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies
por: Beukenhorst, Anna L., et al.
Publicado: (2023)

The value of serology testing to manage SARS-CoV-2 infections
por: Fernández-Barat, Laia, et al.
Publicado: (2020)

Serological chemiluminescence immunoassay for the diagnosis of SARS‐CoV‐2 infection
por: Lijia, Shao, et al.
Publicado: (2020)

Humoral Responses and Serological Assays in SARS-CoV-2 Infections
por: Galipeau, Yannick, et al.
Publicado: (2020)

Clinical characteristics of 9 cancer patients with SARS-CoV-2 infection
por: Zeng, Yong, et al.
Publicado: (2020)

SARS-CoV-2 and the testis: similarity with other viruses and routes of infection
por: Cardona Maya, Walter D., et al.
Publicado: (2020)

“The ancient and the new”: is there an interaction between cytomegalovirus and SARS-CoV-2 infection?
por: Moss, Paul
Publicado: (2020)

Tobacco Products and the Risks of SARS-CoV-2 Infection and COVID-19
por: Samet, Jonathan M
Publicado: (2020)

When is the SARS-CoV-2 infection over and what is post-COVID?
por: Finsterer, Josef
Publicado: (2022)

SARS-CoV-2 Re-infections: Lessons from Other Coronaviruses
por: van der Hoek, Lia
Publicado: (2020)

Alpha variant SARS-CoV-2 infection: How it all starts
por: Domingo, Pere, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0pgte0glln5ht1bsav5tsqmvmn